*Prices reflect U.S. average retail price

Methylphenidate, sold under various trade names, Ritalin being one of the most commonly known, is a central nervous system (CNS) stimulant of the phenethylamine and piperidine classes that is used in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. The original patent was owned by CIBA, now Novartis Corporation. It was first licensed by the US Food and Drug Administration (FDA) in 1955 for treating what was then known as hyperactivity... Wikipedia

Manufacturer's Website: Not Available                                                                                                                   Average retail cost: $59/month

Phentermine (contracted from phenyl-tertiary-butylamine), also known as α,α-dimethylphenethylamine, is a psychostimulant drug of the substituted amphetamine chemical class, with pharmacology similar to amphetamine. It is used medically as an appetite suppressant for short term use, as an adjunct to exercise and reducing calorie intake... Wikipedia

Manufacturer's Website: Not Available                                                                                                                     Average retail cost: $104/month

Dexmethylphenidate, sold under the trade names Focalin among others, is a central nervous system (CNS) stimulant used in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy... Wikipedia

Manufacturer's Website: Not Available                                                                                                                 Average retail cost: $134/month

Methylphenidate, sold under various trade names, Ritalin being one of the most commonly known, is a central nervous system (CNS) stimulant of the phenethylamine and piperidine classes that is used in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. The original patent was owned by CIBA, now Novartis Corporation. It was first licensed by the US Food and Drug Administration (FDA) in 1955 for treating what was then known as hyperactivity... Wikipedia

Manufacturer's Website: Ritalin                                                                                                                                Average retail cost: $132/month

Adderall, Adderall XR, and Mydayis are combination drugs containing four salts of the two enantiomers of amphetamine, a central nervous system (CNS) stimulant of the phenethylamine class. Adderall is used in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. It is also used as an athletic performance enhancer and cognitive enhancer, and recreationally as an aphrodisiac and euphoriant... Wikipedia

Manufacturer's Website: Not Available                                                                                                                      Average retail cost: $255/month

Methylphenidate, sold under various trade names, Ritalin being one of the most commonly known, is a central nervous system (CNS) stimulant of the phenethylamine and piperidine classes that is used in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. The original patent was owned by CIBA, now Novartis Corporation. It was first licensed by the US Food and Drug Administration (FDA) in 1955 for treating what was then known as hyperactivity... Wikipedia

Manufacturer's Website: Aptensio XR                                                                                                                           Average retail cost: $305/month

Amphetamine (contracted from alpha-methylphenethylamine) is a potent central nervous system (CNS) stimulant that is used in the treatment of attention deficit hyperactivity disorder (ADHD), narcolepsy, and obesity. Amphetamine was discovered in 1887 and exists as two enantiomers: levoamphetamine and dextroamphetamine... Wikipedia

Manufacturer's Website: Evekeo                                                                                                                                  Average retail cost: $538/month

Benzphetamine (brand name Didrex) is a substituted amphetamine used short-term along with a doctor-approved, reduced-calorie diet, exercise, and behavioral program for weight loss. It is prescribed for obesity in individuals who have been unable to lose weight through exercise and dieting alone. It is a prodrug to amphetamine... Wikipedia

Manufacturer's Website: Quillivant                                                                                                                         Average retail cost: $402/month

Lisdexamfetamine (contracted from L-lysine-dextroamphetamine) is a prodrug of the central nervous system (CNS) stimulant dextroamphetamine, a phenethylamine of the amphetamine class that is used in the treatment of attention deficit hyperactivity disorder (ADHD) and binge eating disorder... Wikipedia

Manufacturer's Website: Vyvanse                                                                                                                   Average retail cost: $489/month

Methylphenidate, sold under various trade names, Ritalin being one of the most commonly known, is a central nervous system (CNS) stimulant of the phenethylamine and piperidine classes that is used in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. The original patent was owned by CIBA, now Novartis Corporation. It was first licensed by the US Food and Drug Administration (FDA) in 1955 for treating what was then known as hyperactivity... Wikipedia

Manufacturer's Website: Ritalin                                                                                                                      Average retail cost: $426/month

Methylphenidate, sold under various trade names, Ritalin being one of the most commonly known, is a central nervous system (CNS) stimulant of the phenethylamine and piperidine classes that is used in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. The original patent was owned by CIBA, now Novartis Corporation. It was first licensed by the US Food and Drug Administration (FDA) in 1955 for treating what was then known as hyperactivity... Wikipedia

Manufacturer's Website: Daytrana                                                                                                              Average retail cost: $548/month

Methylphenidate, sold under various trade names, Ritalin being one of the most commonly known, is a central nervous system (CNS) stimulant of the phenethylamine and piperidine classes that is used in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. The original patent was owned by CIBA, now Novartis Corporation. It was first licensed by the US Food and Drug Administration (FDA) in 1955 for treating what was then known as hyperactivity... Wikipedia

Manufacturer's Website: Concerta                                                                                                                           Average retail cost: $570/month

Dexmethylphenidate, sold under the trade names Focalin among others, is a central nervous system (CNS) stimulant used in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy... Wikipedia

Manufacturer's Website: Focalin                                                                                                                       Average retail cost: $574/month

Adderall, Adderall XR, and Mydayis are combination drugs containing four salts of the two enantiomers of amphetamine, a central nervous system (CNS) stimulant of the phenethylamine class. Adderall is used in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. It is also used as an athletic performance enhancer and cognitive enhancer, and recreationally as an aphrodisiac and euphoriant... Wikipedia

Manufacturer's Website: Not Available                                                                                                             Average retail cost: $350/month

Methylphenidate, sold under various trade names, Ritalin being one of the most commonly known, is a central nervous system (CNS) stimulant of the phenethylamine and piperidine classes that is used in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. The original patent was owned by CIBA, now Novartis Corporation. It was first licensed by the US Food and Drug Administration (FDA) in 1955 for treating what was then known as hyperactivity... Wikipedia

Manufacturer's Website: Quillichew                                                                                                           Average retail cost: $442/month

Amphetamine is a potent central nervous system (CNS) stimulant that is used in the treatment of attention deficit hyperactivity disorder (ADHD), narcolepsy, and obesity... Wikipedia

Manufacturer's Website: Adzenys                                                                                                                  Average retail cost: $567/month

Atomoxetine, sold under the brand name Strattera among others, is a norepinephrine (noradrenaline) reuptake inhibitor which is approved for the treatment of attention deficit hyperactivity disorder (ADHD)... Wikipedia

Manufacturer's Website: Strattera                                                                                                                     Average retail cost: $522/month

Adderall, Adderall XR, and Mydayis are combination drugs containing four salts of the two enantiomers of amphetamine, a central nervous system (CNS) stimulant of the phenethylamine class. Adderall is used in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy... Wikipedia

Manufacturer's Website: Mydayis                                                                                                                      Average retail cost: $434/month

Amphetamine is a potent central nervous system (CNS) stimulant that is used in the treatment of attention deficit hyperactivity disorder (ADHD), narcolepsy, and obesity... Wikipedia

Manufacturer's Website: Dyanavel                                                                                                                       Average retail cost: $504/month

Armodafinil (trade name Nuvigil) is the enantiopure compound of the eugeroic modafinil (Provigil)] It consists of only the (R)-(−)-enantiomer of the racemic modafinil. Armodafinil is produced by the pharmaceutical company Cephalon Inc] and was approved by the U.S. Food and Drug Administration (FDA) in June 2007... Wikipedia

Manufacturer's Website: Nuvigil                                                                                                                          Average retail cost: $1,217/month

Methamphetamine in the United States is regulated under Schedule II of the Controlled Substances Act. It is approved for extremely limited pharmacological use in the treatment of attention deficit hyperactivity disorder and treatment-resistant obesity, but it is primarily used as a recreational drug... Wikipedia

Manufacturer's Website: Not Available                                                                                                          Average retail cost: $1,475/month

Dextroamphetamine is a potent central nervous system (CNS) stimulant and amphetamine enantiomer that is prescribed for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. It is also used as an athletic performance and cognitive enhancer, and recreationally as an aphrodisiac and euphoriant... Wikipedia

Manufacturer's Website: Not Available                                                                                                                   Average retail cost: $609/month

Modafinil, sold under the brand name Provigil among others, is a wakefulness-promoting drug used for treatment of disorders such as narcolepsy, shift work sleep disorder, idiopathic hypersomnia, and excessive daytime sleepiness associated with obstructive sleep apnea. It has also seen widespread off-label use as a purported cognitive enhancer... Wikipedia

Manufacturer's Website: Not Available                                                                                                                Average retail cost: $2,590/month